LLY

1,009.78

+2.29%↑

JNJ

230.21

+1.07%↑

ABBV

213.46

+1.18%↑

UNH

393.26

+1.95%↑

AZN

185.37

+0.94%↑

LLY

1,009.78

+2.29%↑

JNJ

230.21

+1.07%↑

ABBV

213.46

+1.18%↑

UNH

393.26

+1.95%↑

AZN

185.37

+0.94%↑

LLY

1,009.78

+2.29%↑

JNJ

230.21

+1.07%↑

ABBV

213.46

+1.18%↑

UNH

393.26

+1.95%↑

AZN

185.37

+0.94%↑

LLY

1,009.78

+2.29%↑

JNJ

230.21

+1.07%↑

ABBV

213.46

+1.18%↑

UNH

393.26

+1.95%↑

AZN

185.37

+0.94%↑

LLY

1,009.78

+2.29%↑

JNJ

230.21

+1.07%↑

ABBV

213.46

+1.18%↑

UNH

393.26

+1.95%↑

AZN

185.37

+0.94%↑

Home・Lista de Ações・Pacific Biosciences of California Inc

Pacific Biosciences of California Inc

Abrir

SetorSaúde

1.12 -1.75

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

1.12

Máximo

1.19

Indicadores-chave
By Trading Economics
Rendimento	32M -8.3M
Vendas	-7.5M 37M
EPS	-0.12
Margem de lucro	-22.258
Funcionários	485
EBITDA	509K -38M

Recomendações
By TipRanks
Recomendações	Neutro
Previsão para 12 meses	+112.5% upside

Dividendos
By Dow Jones
Próximos Ganhos	6 de ago. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-60M 421M
Abertura anterior	2.87
Fecho anterior	1.12

Sentimento de Notícias

By Acuity

64%

36%

293 / 345 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

1.13 / N/A Suporte e Resistência

Pacific Biosciences of California Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

18 de mai. de 2026, 23:10 UTC

Ações em Alta

Stocks to Watch: Agilysys, XP

18 de mai. de 2026, 18:44 UTC

Grandes Movimentos do Mercado

Claritev Shares Recover After Comments About DOJ

18 de mai. de 2026, 23:55 UTC

Ganhos

Review & Preview: Earnings' Last Gasp -- Barrons.com

18 de mai. de 2026, 23:47 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

18 de mai. de 2026, 23:47 UTC

Conversa de Mercado

Nikkei May Rise on Hopes for U.S.-Iran Deal -- Market Talk

18 de mai. de 2026, 23:37 UTC

Conversa de Mercado

Gold Rises Amid Hopes for U.S.-Iran Peace Deal -- Market Talk

18 de mai. de 2026, 22:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Lens Technology Ju Teng International Shares to Resume Trading on Hong Kong Exchange on May 19

18 de mai. de 2026, 22:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Lens Technology: Acquisition of Remaining Ju Teng International Shares to Cost HK$1.91B

18 de mai. de 2026, 22:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Lens Technology to Make Offer for Remainder Shares of Ju Teng International Only After Completion of Stake Purchase

18 de mai. de 2026, 22:25 UTC

Aquisições, Fusões, Aquisições de Empresas

Lens Technology to Acquire 333.71M Ju Teng International Shares for HK$2.20 Each

18 de mai. de 2026, 22:24 UTC

Aquisições, Fusões, Aquisições de Empresas

Lens Technology to Acquire 27.81% Stake in Ju Teng International for HK$734.17M

18 de mai. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

18 de mai. de 2026, 20:50 UTC

Conversa de Mercado

Aquisições, Fusões, Aquisições de Empresas

Financial Services Roundup: Market Talk

18 de mai. de 2026, 20:25 UTC

Ganhos

Correct: XP 1Q Total Client Assets BRL1.53T

18 de mai. de 2026, 20:23 UTC

Ganhos

XP 1Q Total Client Assets BRL1.53B

18 de mai. de 2026, 20:19 UTC

Ganhos

XP 1Q Adj EPS BRL2.49 >XP

18 de mai. de 2026, 20:19 UTC

Ganhos

XP 1Q Rev BRL4.73B >XP

18 de mai. de 2026, 19:10 UTC

Conversa de Mercado

Oil Presses Higher With No Hormuz Reopening in Sight -- Market Talk

18 de mai. de 2026, 19:00 UTC

Ganhos

5 Stocks with 5% Yields and Market-Beating Returns -- Barrons.com

18 de mai. de 2026, 18:52 UTC

Conversa de Mercado

U.S. Natural Gas Futures Gain As Weather Heats Up -- Market Talk

18 de mai. de 2026, 18:17 UTC

Conversa de Mercado

Aquisições, Fusões, Aquisições de Empresas

NextEra's Dominion Acquisition Unlikely to Spur Wider Utility Consolidation -- Market Talk

18 de mai. de 2026, 17:22 UTC

Conversa de Mercado

Tokenized Assets Expected to be Over $1T By 2030 -- Market Talk

18 de mai. de 2026, 16:57 UTC

Aquisições, Fusões, Aquisições de Empresas

The Long Regulatory Road Ahead for the NextEra-Dominion Deal -- Barrons.com

18 de mai. de 2026, 16:57 UTC

Conversa de Mercado

Global Energy Roundup: Market Talk

18 de mai. de 2026, 16:57 UTC

Conversa de Mercado

Commodities Higher as Traders Want Physical Assets -- Market Talk

18 de mai. de 2026, 16:54 UTC

Aquisições, Fusões, Aquisições de Empresas

Vinci Doesn't Set Out Financial Details of Deal

18 de mai. de 2026, 16:50 UTC

Aquisições, Fusões, Aquisições de Empresas

Vinci: Acquisition of New Brunswick-Based Group Stregthens Presence in Eastern Canada

18 de mai. de 2026, 16:49 UTC

Aquisições, Fusões, Aquisições de Empresas

Vinci: Modern Group is Roadwork, Civil Engineering Specialist

18 de mai. de 2026, 16:49 UTC

Aquisições, Fusões, Aquisições de Empresas

Vinci: Modern Group Made Revenue of Around 50 Mln Euros Last Year

18 de mai. de 2026, 16:48 UTC

Aquisições, Fusões, Aquisições de Empresas

Vinci Buys Canada's Modern Group of Companies

Comparação entre Pares

Variação de preço

Pacific Biosciences of California Inc Previsão

Preço-alvo

By TipRanks

112.5% parte superior

Previsão para 12 meses

Média 2.38 USD 112.5%

Máximo 3 USD

Mínimo 1.5 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Pacific Biosciences of California Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

4 ratings

Comprar

Manter

Vender

Com base em 4 analistas que deram avaliações de ações para Pacific Biosciences of California Inc - Dist nos últimos 3 meses.

Pontuação Técnica

By Trading Central

1.13 / N/ASuporte e Resistência

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

There is one bearish event.

Sentimento

By Acuity

293 / 345 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Pacific Biosciences of California Inc

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.